Pay in 4 interest-free payments of $6.18 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
Its core features help simplify a complex regimen: Easy shot logging : record injection dates, times and locations
Key mechanisms include: Enhanced Glucose-Dependent Insulin Secretion: GLP-1 receptor stimulation amplifies insulin release only in the presence of glucose, minimizing hypoglycemia risk
10.1177/0091270008325152 89 HulinB.CabralS.LopazeM
NIH Image to ImageJ: 25 years of image analysis
Reconstituted: Refrigerate at 28 C (35.646.4 F) , protected from light, and use within about 14 days
Each receptor contributes distinct effects: GLP-1 Receptor Component Glucose-dependent insulin secretion from pancreatic beta cells Glucagon suppression in pancreatic alpha cells Slowed gastric emptying Hypothalamic appetite reduction GIP Receptor Component Additional insulin secretion enhancement (synergistic with GLP-1) Direct adipose tissue effects on lipid metabolism Centrally mediated appetite effects via brain GIP receptors Glucagon Receptor Component (Unique to Retatrutide) Increased energy expenditure glucagon receptor activity raises metabolic rate Hepatic glucose output modulation increases glucose production in liver (counterbalanced by GLP-1s insulin effects) Direct fatty acid oxidation effects in liver and muscle tissue Body composition effects from energy expenditure changes The glucagon receptor component is what makes retatrutide unique
US$ 25.44
US$ 26.59
US$ 24.95
US$ 22.87
US$ 28.98
